← back to search

Pengfei Liu

Shangqiu Normal University · CN
Area of research
Cancer Research · Pulmonary and Respiratory Medicine
Research interest
Research interests include MicroRNA in disease regulation, Cancer-related molecular mechanisms research, Ferroptosis and cancer prognosis, and RNA modifications and cancer.
h-index
19
citations
1,451
works
117
NIH funding
primary concept
email

Recent publications

EZH2 regulates pancreatic cancer cells through E2F1, GLI1, CDK3, and Mcm4
Hereditas 2023cited by 16position: lastdoi
Dual Function of CCAT2 in Regulating Luminal Subtype of Breast Cancer Depending on the Subcellular Distribution
Cancers 2023cited by 7position: middledoi
miR-17-5p promotes the invasion and migration of colorectal cancer by regulating HSPB2
Journal of Cancer 2022cited by 29position: middledoi
Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis
BMC Cancer 2021cited by 55position: lastdoi
Mechanical properties of de-epithelialized tracheal allografts
Journal of Thoracic Disease 2021cited by 9position: middledoi
miR-17-5p promotes the invasion and migration of colorectal cancer by regulating HSPB2
Research Square 2021cited by 2position: middledoi
miR-17-5p Promotes the Invasion and Migration of Colorectal Cancer by Regulating HSPB2
Research Square 2020cited by 1position: middledoi
miR-17-5p promotes the invasion and migration of colorectal cancer by regulating HSPB2
Research Square 2020cited by 0position: middledoi
Differential and overlapping targets of the transcriptional regulators NRF1, NRF2, and NRF3 in human cells
Journal of Biological Chemistry 2019cited by 82position: firstdoi
Somatic gene mutation signatures predict cancer type and prognosis in multiple cancers with pan-cancer 1000 gene panel
Cancer Letters 2019cited by 27position: middledoi
The technical characteristics and clinical analysis of laparoscopic bursectomy for advanced gastric cancer
Annals of Laparoscopic and Endoscopic Surgery 2017cited by 0position: middledoi
EGFR gene copy number as a predictive biomarker for resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer treatment: a meta-analysis.
PubMed 2014cited by 17position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Jia Wang · China Agricultural University4 papers (2020–2022)Shuangshuang Han · Nankai University4 papers (2020–2022)Zengren Zhao · Hebei Medical University4 papers (2020–2022)Mingda Xuan · Hebei Medical University4 papers (2020–2022)Yingfu Zhang · Hebei Medical University3 papers (2020–2022)Chao Li · Kunming University of Science and Technology3 papers (2020–2022)Hailong Wang · Nanchang University2 papers (2019–2023)Xiaowei Wang · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2019–2021)Weifang Yu · First Affiliated Hospital of Hebei Medical University2 papers (2021–2022)Wei Yu · Northeast Agricultural University2 papers (2020–2020)Wenhua Jiang · Jilin University2 papers (2019–2023)Da Jiang · Wuhan Polytechnic University2 papers (2019–2021) · 2 papers (2019–2021)Hailong Wang · Zhongyuan University of Technology1 papers (2021–2021)Yong Liu · Wenzhou University1 papers (2019–2019)Ying Li · Shenyang Medical College1 papers (2021–2021)Ying Li · Luohe Medical College1 papers (2023–2023)Zhenzhen Zhang · China Tobacco1 papers (2019–2019)Tian Wang · Boston University1 papers (2019–2019)Han Wang · Fujian Medical University1 papers (2019–2019)